StockNews.com Initiates Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX)
StockNews.com started coverage on Brooklyn ImmunoTherapeutics in a research report on Thursday. They issued a "hold" rating for the company.
Publicado el: 2025-05-03 05:17:22
Autor: lulegacy, Fuente: lulegacy
Compartir: 
